LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global Addison’s disease therapeutics market is expected to post a
CAGR of close to 4% during the period 2019-2023, according to the latest
market research report by Technavio.
A key factor driving the growth of the global Addison’s disease
therapeutics market is the reformulation of drugs. The modified-release,
sustained-release, extended-release, controlled-release, and
prolonged-release versions of existing oral corticosteroid are gaining
immense traction. This is mainly due to the pharmacodynamic and
pharmacokinetic advantages of these versions over the conventional
dosage forms. For instance, the prolonged action dosage forms maximize
the bioavailability of the drug with a minimum dose and increase the
rate as well as the extent of drug absorption. These benefits have led
to the emergence of the reformulated versions of corticosteroids, which
helps in the adequate maintenance of corticosteroid levels in the
patients with Addison’s disease.
As per Technavio, the expanding research into the development of
regenerative therapy will have a positive impact on the market and
contribute to its growth significantly over the forecast period. This global
Addison’s disease therapeutics market 2019-2023
research report also analyzes other significant trends and
market drivers that will affect market growth over 2019-2023.
Global Addison’s disease therapeutics market:
Expanding research into the development of regenerative therapy
Currently, the options available for the treatment of Addison’s disease
involve the life-long use of exogenous corticosteroids. The long-term
use of these drugs predisposes the patients to a range of harmful side
effects such as buffalo hump, headache, muscle weakness, cataract,
glaucoma, facial hair growth, and puffiness of the face. Thus,
researchers are focusing on the development of regenerative therapies
for the treatment of Addison’s disease to reduce the duration of therapy
and overcome these side effects. The adoption of regenerative medicines
will significantly increase due to their minimal side effects and
curative nature. Various research institutions and companies are
investing in R&D of these medicines for curing rare and orphan diseases
including Addison’s disease. Such expanding research on the development
of regenerative therapy will positively impact market growth during the
forecast period.
“Apart from the expanding research into the development of
regenerative therapies, factors such as the availability of clinical
guidelines, redefined pathophysiology, and the adverse effects
associated with available drugs are expected to have a significant
impact on the growth of the Addison’s disease therapeutics market during
the forecast period,” says a senior research analyst at Technavio.
Global Addison’s disease therapeutics market:
Segmentation analysis
This market research report segments the global Addison’s disease
therapeutics market by product (oral drugs, and parenteral drugs) and
geographic regions (North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by Europe,
Asia, and ROW respectively. The market growth in North American can be
attributed to the presence of favorable reimbursement schemes, the
increasing awareness about the diagnosis and effective management of
Addison’s disease, and the market entry of orphan drugs with expanded
exclusivity rights.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com